NCT04932525

Gustave Roussy Cancer Profiling

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20,000 (estimated)
• Sponsor: Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.

Detailed description

STING is a biology driven, multicenter study designed to identify actionable molecular alterations in cancer patients and to explore mechanisms of sensitivity and resistance to anti-cancer treatment * In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling * Patients included in the STING study and for whom a targetable genomic alteration had been identified might be subsequently included in a clinical trial running at Gustave Roussy or another participating center.

Conditions

• Solid Tumor, Unspecified, Adult

Interventions

Type	Name	Description
PROCEDURE	Biopsy	Blood and tumor samples for Genetic Profiling research

Timeline

• Start date: 2021-05-10
• Primary completion: 2033-05-10
• Completion: 2033-05-10
• First posted: 2021-06-21
• Last updated: 2026-02-06

Locations

4 sites across 1 country: France